CoChat

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients

Open access
Álvarez-López, Patricia, Riveiro-Barciela, Mar, Oleas-Vega, Diana, Flores-Cortes, Claudia, Román, Antonio, Perelló, Manel, Berastegui, Cristina, Castells, Lluis, Esteban, Rafael, Buti, María · 2020 · Medicine

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Immunosuppression can lead to hepatitis B virus (HBV) reactivation in hepatitis B core antigen antibodies (anti-HBc) positive patients, especially those undergoing chemotherapy, although there is limited data on solid organ recipients, especially lung transplantation. Our aim was to analyze the risk of HBV reactivation and the potential impact of anti-HBc-positive status (both donors and recipients) on prognosis in a lung, kidney, and liver transplantation cohort. Retrospective analysis including data from all transplants in adults (2011–2012) in a tertiary hospital, with prospective HBV serology study to assess the risk of reactivation and its possible impact on survival. In total, 392 transplant recipients were included (196 kidney, 113 lung, 83 liver). Pre-transplantation anti-HBc screening was more frequent in liver recipients (P < .001) and donors (P < .001) than in kidney or lung. Fifty-five (14%) recipients were anti-HBc-positive and were not undergoing antiviral prophylaxis. Three (5.4%) cases of HBV reactivation occurred: 2 in pre-transplant anti-HBc-positive recipients and 1 with prior unknown anti-HBc status. All were HBeAg+ with HBV deoxyribonucleic acid (DNA) >10E8 IU/mL and only mild fibrosis. Baseline recipient anti-HBc positive status was the only factor associated with HBV reactivation. No reactivation cases occurred in lung or kidney recipients of anti-HBc positive grafts. Survival was lower in lung transplants, especially in human immunodeficiency virus-infected patients and those with prior immunosuppression. Anti-HBc positive status is a risk factor for HBV reactivation in solid organ recipients. Anti-HBc testing is highly recommended in solid-organ transplant recipients in order to identify those anti-HBc positive and therefore candidates for periodical hepatitis B surface antigen (HBsAg) and HBV DNA screening after transplant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000019407

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Percentage of recipients and donors screened in each graft type and percentage testing anti-HBc positive. anti-HBc = hepatitis B core antigen antibodies.
Figure 1 Percentage of recipients and donors screened in each graft type and percentage testing anti-HBc positive. anti-HBc = hepatitis B core antigen antibodies.CC BY-NC · PubMed Central
Figure 2 Mortality by type of transplanted solid organ.
Figure 2 Mortality by type of transplanted solid organ.CC BY-NC · PubMed Central
Figure 3 Percentage of recipients who underwent prospective HBsAg screening and percentage testing positive according to their pre-transplant anti-HBc status. ∗anti-HBc positive recipients without antiviral prophylaxis. anti-HBc = hepatitis B core antigen antibodies, HBsAg = hepatitis B surface antigen.
Figure 3 Percentage of recipients who underwent prospective HBsAg screening and percentage testing positive according to their pre-transplant anti-HBc status. ∗anti-HBc positive recipients without antiviral prophylaxis. anti-HBc = hepatitis B core antigen antibodies, HBsAg = hepatitis B surface antigen.CC BY-NC · PubMed Central
Figure 4 Percentage of anti-HBc positive recipients who underwent post-transplantation HBsAg screening and percentage testing positive according to the transplanted solid organ. anti-HBc = hepatitis B core antigen antibodies, HBsAg = hepatitis B surface antigen.
Figure 4 Percentage of anti-HBc positive recipients who underwent post-transplantation HBsAg screening and percentage testing positive according to the transplanted solid organ. anti-HBc = hepatitis B core antigen antibodies, HBsAg = hepatitis B surface antigen.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 1

  1. Gonzalez, 2016, Hepatitis b reactivation among non-liver solid organ transplant recipients, Am J Transplant, 13

Cited by

See all 15

Metadata

Authors
Álvarez-López, P., Riveiro-Barciela, M., Oleas-Vega, D., Flores-Cortes, C., Román, A., Perelló, M., Berastegui, C., Castells, L., Esteban, R., & Buti, M.
Affiliations
  • Liver Unit, Internal Medicine Department
  • Nephrology Department
  • Vall d'Hebron Hospital Universitari (ES)
  • Instituto de Salud Carlos III (ES)
Venue
Medicine
Published
2020-02
Volume
99
Issue
9
Pages
e19407
ISSN
  • 0025-7974 (ISSN-L)
  • 1536-5964
OpenAlex
W3010313192
Cited by
15
References
23
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2
FWCI
1.26
Type
journal article
Language
en
Open access
Locations
  • Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
HBV reactivation, anti-HBc, solid organ transplantation, lung transplantation, kidney transplantation, liver transplantation, immunosuppression, transplant recipient survival, HIV infection, HBV DNA, HBeAg
MeSH terms
Adult, Aged, Female, Hepatitis B, Hepatitis B Core Antigens, Humans, Male, Middle Aged, Prospective Studies, Retrospective Studies, Spain, Virus Activation, Survival Analysis, Organ Transplantation, Risk Assessment, Transplant Recipients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients. https://app.cochat.ai/papers/10.1097/md.0000000000019407
The paper
Álvarez-López, P., Riveiro-Barciela, M., Oleas-Vega, D., Flores-Cortes, C., Román, A., Perelló, M., Berastegui, C., Castells, L., Esteban, R., & Buti, M. (2020). Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients. Medicine. https://doi.org/10.1097/md.0000000000019407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.